- Home
- PRTG vs APDN Comparison
PRTG vs APDN Comparison
Compare PRTG & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTG
- APDN
- Stock Information
- Founded
- PRTG 1973
- APDN 1983
- Country
- PRTG British Virgin Islands
- APDN United States
- Employees
- PRTG N/A
- APDN N/A
- Industry
- PRTG Oil & Gas Production
- APDN Other Consumer Services
- Sector
- PRTG Energy
- APDN Consumer Discretionary
- Exchange
- PRTG Nasdaq
- APDN Nasdaq
- Market Cap
- PRTG 8.1M
- APDN 9.4M
- IPO Year
- PRTG N/A
- APDN N/A
- Fundamental
- Price
- PRTG $4.57
- APDN $0.16
- Analyst Decision
- PRTG
- APDN Strong Buy
- Analyst Count
- PRTG 0
- APDN 1
- Target Price
- PRTG N/A
- APDN $1.50
- AVG Volume (30 Days)
- PRTG 129.9K
- APDN 2.0M
- Earning Date
- PRTG 03-03-2025
- APDN 02-13-2025
- Dividend Yield
- PRTG N/A
- APDN N/A
- EPS Growth
- PRTG N/A
- APDN N/A
- EPS
- PRTG N/A
- APDN N/A
- Revenue
- PRTG N/A
- APDN $3,736,873.00
- Revenue This Year
- PRTG N/A
- APDN $54.72
- Revenue Next Year
- PRTG N/A
- APDN N/A
- P/E Ratio
- PRTG N/A
- APDN N/A
- Revenue Growth
- PRTG N/A
- APDN N/A
- 52 Week Low
- PRTG $2.10
- APDN $0.12
- 52 Week High
- PRTG $23.01
- APDN $14.40
- Technical
- Relative Strength Index (RSI)
- PRTG 48.57
- APDN 38.90
- Support Level
- PRTG $4.46
- APDN $0.16
- Resistance Level
- PRTG $5.00
- APDN $0.21
- Average True Range (ATR)
- PRTG 0.61
- APDN 0.01
- MACD
- PRTG 0.00
- APDN -0.00
- Stochastic Oscillator
- PRTG 50.00
- APDN 17.50
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.